BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
3.730
+0.040 (1.08%)
Jan 16, 2026, 11:48 AM EST - Market open
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $8.82 million as of January 16, 2026. Its market cap has increased by 75.82% in one year.
Market Cap
8.82M
Enterprise Value
6.06M
1-Year Change
75.82%
Ranking
Category
Stock Price
$3.73
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $8.82M, a decrease of -79.07%. That is a compound annual growth rate of -25.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 8.72M | -6.58% |
| Dec 31, 2025 | 9.34M | 85.79% |
| Dec 31, 2024 | 5.03M | -46.33% |
| Dec 29, 2023 | 9.36M | -94.33% |
| Dec 30, 2022 | 165.03M | -54.75% |
| Dec 31, 2021 | 364.69M | 54.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Linde | 206.10B |
| BHP Group | 167.61B |
| Southern Copper | 146.99B |
| Rio Tinto Group | 143.60B |
| Newmont | 124.01B |
| Agnico Eagle Mines | 99.41B |
| The Sherwin-Williams Company | 88.04B |
| Freeport-McMoRan | 84.98B |